HealthcareNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1735438MGTX stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

MGTX Stock Analysis & AI Quality Score

AI stock analysis and institutional research for MeiraGTx Holdings plc (MGTX), a Healthcare sector company. MGTX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), MeiraGTx Holdings plc reports quarterly revenue of $293.0K, net income of $-46.3M, free cash flow of $15.8M. Top institutional holders of MGTX by reported 13-F value include Sanofi, PERCEPTIVE ADVISORS, Rubric Capital Management, based on the most recent SEC filings. MGTX trades on the Nasdaq exchange and files with the SEC under CIK 1735438. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MGTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MeiraGTx Holdings plc directly from SEC EDGAR.

Revenue

Q1 2026

$293.0K

Net Income

Q1 2026

$-46.3M

Free Cash Flow

Q1 2026

$15.8M

Get alerted when MGTX's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for MeiraGTx Holdings plc including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of MGTX

Put MGTX on your watchlist

Track score changes the day MeiraGTx Holdings plc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is MGTX a good stock to buy?

13F Pro's AI-powered analysis of MeiraGTx Holdings plc (MGTX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MGTX are available on the MGTX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own MGTX?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MGTX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MeiraGTx Holdings plc's investment landscape.